- within Corporate/Commercial Law topic(s)
- in United States
- with readers working within the Accounting & Consultancy industries
- within Wealth Management, Employment and HR and Transport topic(s)
- with Senior Company Executives, HR and Inhouse Counsel
Buyout activity slowed further in early 2026
Asia saw low levels of M&A activity in Q1 2026, and this was also seen in the buyout space. The level of buyout activity was well below both the value and volume seen in Q1 over the last few years, with values falling below Q1 2024, which was a particularly slow-starting year. This continues the stop-start approach to deal making that we have seen in private capital markets in recent quarters. Given the magnitude of the drop in both deal value and volume in early 2026, there appears to be a broad-based slowdown rather than a shift towards smaller or more opportunistic transactions.
While Q1 is typically characterised by early year softness, the extent of the decline indicates that the current geopolitical uncertainty, valuation gaps and financing considerations continue to constrain transaction execution.
The impact of the war in the Middle East is affecting market sentiment and will continue to do so as people reassess their global allocations. We spoke last year of the decline of allocations to the US, and we are now hearing an increasingly positive sentiment to greater allocations to north Asia - it being seen as more stable in the short-medium term with bright spots such as the Hong Kong IPO market continuing to drive growth.
Consumer and industrials lead Q1 buyout activity

Source: Preqin, data as of 2nd Apirl 2026
Established markets continue to account for the majority of activity
China remained the largest M&A market by deal value in Q1 2026, although activity moderated following the rebound during 2025. Japan continued to rank second, supported by domestic consolidation and sponsor involvement, but also experienced a noticeable deceleration at the start of the year. These two markets will be key drivers of private capital activity in the coming year. In China, reforms to boost domestic consumption and a sense that the property market has stabilised have given a greater sense of optimism. Japan is also on private capital’s radar for carve outs driven by corporate governance reforms and the weak yen is also providing value.
India remained among the more active markets, driven by ongoing consolidation and sponsor led transactions, although volumes were below levels observed in earlier peak periods. Korea and Singapore also recorded lower activity levels, reflecting a generally cautious regional environment rather than market specific factors.
Japan continues to show signs of slowing

Source: Preqin, data as of 2nd April 2026
Sector trends: familiar leaders, lower volumes
Industrials, financial services and technology continued to account for the largest share of Asia M&A deal value - although no sector was immune to the general slowdown in activity. These sectors have consistently underpinned regional activity, supported by long-term themes such as digitalisation, infrastructure investment and financial sector restructuring. It will be interesting to see how the nervousness in the markets around private credit’s exposure to technology and the disruption caused by AI will affect these sectors in Asia, but, for the moment at least, we are still seeing strong interest, particularly in digital infrastructure.
Asia M&A activity 2019-YTD 2026: Target industry by deal value (USD)

Source: LSEG, Asia target company, announced deals between Jan 2019 – YTD 2026. Deal status: completed or pending
Heightened uncertainty
While Asia M&A activity was subdued at the start of 2026, engagement levels and deal pipelines still remained reasonably robust. EQT’s closing of Asia Pacific's largest ever private equity fund at US$15.6 billion shows that there is strong investor appetite for the region (albeit with the announced closing coming shortly after the end of Q1 so not quite early enough to be in the data). Interestingly, the fund attracted 75 new investors with a globally diversified investor base – supporting the view that Asia could see an uptick in allocations as investors rebalance geographical weightings.
We expect activity to recover gradually as the year progresses, supported by increasing pressure to deploy capital, create exit opportunities and pursue strategic consolidation. As we discuss below, secondaries could be coming of age in Asia to support increased exit opportunities. Although any recovery is likely to be uneven, with geopolitical and regulatory considerations continuing to act as constraints on execution.
Asia fundraising drops further, all eyes on secondaries
Continued pressure on Asia fundraising amid geopolitical uncertainty
Fundraising in Asia dropped to another low in Q1 2026. While Q4 2025 saw the usual uptick in capital raised due to several closings late in the year, the size of that uptick was well below the Q4 upticks in previous years - and even this small momentum did not carry forward into Q1.
Quarterly Asia private capital fundraising

Source: Pitchbook, based on capital raised by closed funds
Interestingly, while in previous years the number of funds holding a closing jumped in Q4 alongside volume raised, this was not the case in 2025. This reflects the extremely difficult fundraising conditions for many GPs.
Fundraising declined across all asset classes. Secondaries fundraising, which went from strength to strength over the past few years, showed a particularly pronounced decline.
Asia-based secondaries by asset class

Source: Pitchbook, based on capital raised by closed funds
We believe that two main factors are weighing on fundraising:
- geopolitical uncertainty, including more complex sanctions and national security review regimes, such as the US outbound investment rules; and
- distributions are still lagging behind expectations, with IPO exits picking up but not yet fully translating into sufficient return of capital to investors.
Geopolitical uncertainty is limiting deployment by some of the largest investors, which are often sovereign wealth funds. Apart from the obvious concern of geographical selection, these investors are disproportionately affected by changing sanctions regimes and national security reviews. The associated risks necessitate more careful due diligence on funds before investing and sometimes lower commitments to avoid crossing certain ownership thresholds.
The list of the 10 largest funds closed in 2026 so far reflects these circumstances and is dominated by China and India-focussed funds, including four RMB funds. Domestic funds that do not rely on international investors are evidently not as affected by geopolitical headwinds.
| Fund | Fund Size (US$ million) | Geography | Industry | Fund Type |
|---|---|---|---|---|
| A | 1,865.00 | Asia | Logistics | Real Estate Value Added |
| B (RMB Fund) | 1,445.91 | China | Information Technology | Venture - General |
| C (RMB Fund) | 1,015.02 | China | Venture - General | |
| D | 1,000.00 | China | Consumer Products and Services (B2C), Financial Services, Information Technology | Buyout |
| E | 933.58 | India | Consumer Products and Services (B2C), Financial Services, Healthcare, Information Technology | Buyout |
| F (RMB Fund) | 725.80 | China | Energy, Healthcare, Materials and Resources | Venture - General |
| G | 689.07 | South Korea | Energy, Semiconductors | Infrastructure Opportunistic |
| H | 500.00 | Venture - General | ||
| I (RMB Fund) | 489.67 | China | Materials and Resources | Venture - General |
| J | 384.52 | India | Debt - General |
Source: Pitchbook, top 10 Asia based closed funds, Q1 2026
Liquidity in the exit market is still limited, even if improving. The slowdown in secondaries fundraising suggests that secondaries funds raised in previous years still have sufficient capital to deploy and that GPs with eligible assets continue to hold on to these assets for longer.
The latest data shows that GPs have been focussed on generating exits for 2018 vintage funds, while 2019 and 2020 vintage funds continue to lag behind. This may be setting the scene for a strong year for continuation vehicles in Asia.
Newer vintages are showing delayed distribution trajectories

Source: Preqin, median DPI at age of fund
The trend of fundraising shifting to Europe did not carry over into Q1 2026, with early figures for 2026 suggesting that US fundraising has regained its momentum. It is too early to tell of course where fundraising will end up this year, but we can certainly say that US fundraising is not dropping off significantly for now.
We suspect that there are two key factors at play. One might be that the capacity of Europe to absorb the inflows has hit limits. Another may be that the US is still considered the safest place to invest in private assets, with the most sophisticated GPs.
Asia fundraising in Q1 has marginally increased its share of the global total in Q1. We are cautiously optimistic that this trend will continue throughout the year.
Geographical allocation

Source: Pitchbook, based on capital raised by closed funds
All eyes on secondaries
With 2018 to 2020 vintages looking for exits and secondaries funds having sufficient dry powder, many of our conversations with GPs in the recent weeks have centred around secondaries.
We are seeing strong interest in continuation vehicles to allow remaining assets in these funds more runway to exit while generating as much liquidity for existing investors as possible. Judging from our recent conversations with secondaries investors and GPs, more GP-led transactions are likely to come to the market in Asia this year.
As noted in previous editions of our quarterly updates, the Asia secondaries market is disproportionately small compared to Asia's share of global private capital formation, particularly when it comes to GP-led transactions. While continuation vehicles are well established in the US market and increasingly common in the European market, they have been few and far between in Asia.
Consequently, there is limited experience with these transactions among advisers in Asia. This in turn has slowed the development of the secondaries market in Asia, creating a self-limiting cycle.
An increase in continuation vehicle transactions in Asia is an opportunity for advisers to catch up and create a more sophisticated market with Asian characteristics.
Our disputes update below examines the development of continuation vehicles in Asia in further detail. We point out the main risks that Asia GPs should consider when planning a continuation vehicle to avoid disputes with investors – with commentary from our market-leading disputes resolution experts.
Our outlook for the year ahead
From an Asia perspective, the Q1 figures are of course disappointing. However, these figures go against the market sentiment that we observed in Q1. In fact, we generally saw an increase in deal activity and interest in Asia among our clients. We therefore remain cautiously optimistic about Asia fundraising for the remainder of the year, with distinct opportunities for secondaries for 2018 and 2019 vintage funds.
We also expect that the uptick in exit activity via IPOs and secondaries will then translate into increased fundraising activity, and that the headline fundraising figures for Asia will improve in Q3 and Q4. Geopolitical uncertainty remains the main risk factor for private capital fundraising in 2026.
Disputes
Rise of continuation funds and potential for conflict between GPs and LPs
Continuation fund transactions have been increasing globally for several years, and the trend continued in 2025. The data shows approximately 100 transactions with an aggregate value of approximately US$60 billion, dwarfing the number and value of transactions in this space that were happening only a few years ago.
Continuation vehicle fundraising based on closed funds 2020 - 2025 (Global)

Source: Pitchbook, based on capital raised by closed funds
With an increasing number of continuation fund transactions, there is a potential for a greater number of disputes between LPs and GPs. This is because of the inherent challenge GPs face when acting on both sides of the transaction, as the seller (for the original fund) and the buyer (for the continuation fund). Unless the process is managed carefully, allegations of conflicts can easily arise.
One of the most visible examples is the litigation between ADIC and EMG in the US courts in December 2025. In that case, ADIC sought to halt a transaction on the basis that the GP had breached its fiduciary duties to the LPs in the original fund, by selling the asset at an undervalue and providing different information to different investors to get support for the transaction. The result of the litigation was that the transaction was temporarily blocked, pending review by an independent arbiter.
As a result of this case, LPs will be more attuned to their rights and assertive in enforcing them. The volume of transactions, and the inherent risk of conflicts, means that disputes between LPs and GPs in continuation fund deals are likely to increase over the coming years.
Continuation vehicles in Asia and risks arising from lack of expertise
In contrast to the global picture, the use of continuation funds in Asia is much lower and their growth is considerably slower.
Continuation vehicle fundraising based on closed funds 2020 - Q1 2026 (Asia)

Source: Pitchbook, closed funds with a CV fund structure
Although the number of transactions has grown over the past few years, they are still in the single digits, and the aggregate value is around US$1 billion. (The exception was 2022, where a GLP continuation vehicle closed at US$5 billion.)
As noted above, one of the factors limiting the use of continuation vehicles in Asia is a relative lack of adviser expertise and institutional knowledge; in turn, the limited number of deals slows the development of this expertise.
We see this as a risk factor that GPs should take into account when considering a transaction through a continuation fund. Balancing the interests of the investors on both sides of the transaction requires careful handling of the substantive and procedural aspects of the deal. A lack of expertise or attention to detail on these issues can mean that the balance is not achieved, and one set of investors is aggrieved – potentially resulting in litigation as seen in the ADIC/EMG case.
Variance in NAV discounts
Pricing is at the centre of the conflicts of interest that a GP has to manage in connection with a continuation vehicle transaction.
From a global perspective, in 2024 and 2025 assets sold into continuation funds were generally priced at a modest discount to NAV.
Buyout single asset continuation funds weighted average GP-led pricing over time (% of NAV)

Buyout multi-asset continuation funds weighted average GP-led pricing over time (% of NAV)

Roughly two-thirds of transactions (by value) involved a discount to NAV of 5% or less; and around 80% to 90% involved a discount of 10% or less. Single asset funds did not enjoy a noticeably higher price (i.e. lower discount) than multi-asset funds, despite single-asset funds often comprising 'trophy' assets which can command a premium.
However, there are a significant number of transactions that involve a discount of 20% or more. In those cases, LPs may question whether the transaction has been fairly priced and whether the continuation fund investors are getting too much of the upside. It will be important for GPs to be able to demonstrate that the valuation is fair and that proper procedures were used to obtain informed approval for the deal.
Key takeaways
GPs can avoid litigation by structuring the transaction prudently and working with existing LPs and new LPs.
Key sources of disputes between LPs and GPs are likely to be:
- Valuations – are there good grounds for the valuation (eg, a fully informed fairness opinion and/or lead investor scrutiny)?
- Information – has the GP been transparent with the LPs, and provided consistent information to investors on both sides of the deal?
- Procedures – have approval procedures been followed with sufficient time and information for proper deliberations of advisory committees and LPs generally?
If there are shortcomings on these matters, then LPs may have the tools to slow or block deals through action in the courts or arbitral tribunals
SpotlightThe EU AI Act — A wake-up call for Asia-based funds Adelaide Luke, Partner, Head of Competition, Asia The EU AI Act, widely regarded as the world's first comprehensive AI law, governs the offering and use of AI systems that may have an effect in the EU. For Asia-based private equity fund managers, the Act represents a materially different regulatory challenge from traditional European financial regulation, reflecting both the growing use of AI across core fund functions, and the increasingly international footprint of Asian funds. Critically, the Act's jurisdictional reach extends well beyond EU-based entities. Under the Act, companies that are based outside the EU can nonetheless fall within scope where output from an AI system is intended to be used in the EU. This gives the Act a potentially broad extraterritorial effect. For fund managers in Asia Pacific, this is particularly significant. First, many funds have European partners or co-investors, meaning that reporting, valuation or portfolio monitoring outputs generated by AI tools may be directed to, and relied upon by, recipients in the EU. Second, funds with European portfolio company investments will often use AI systems, the output of which feeds into decisions affecting those EU-based businesses, whether in relation to performance oversight, strategic planning or operational management. Third, fund managers increasingly operate through European offices or service providers, meaning that AI-generated outputs used by EU-based staff (for example, in HR, compliance or investment functions) may fall under the Act even where the AI system itself is operated from Asia. A recent industry survey stated that 84% of funds expect AI to have a significant transformative impact on their business. In practice, most Asian fund managers using AI tools with even modest European operations, will likely be caught. Furthermore, if funds modify "out-of-the-box" AI systems or white-label their AI solutions, they risk being considered as a provider of AI — in which case more stringent obligations apply. Diverse high-risk practices
https://digital-strategy.ec.europa.eu/en/factpages/ai-act The Act adopts a risk-based approach. AI systems which are considered to involve significant potential risks to people's health, safety and fundamental rights are classified as "high-risk" and are subject to the greatest degree of regulation. Funds should not assume that only the fund-management aspects of AI (e.g. the monitoring of the performance of European portfolio companies) are worthy of attention. In fact, included in the high-risk category could be AI systems used in HR and employee management. For example, if output from AI tools is used by European HR staff for performance monitoring and recruitment screening, this would be classified as high risk and care should also be taken with AI tools that monitor employee behaviour e.g. communication or attendance monitoring. For funds with European portfolio company investments, AI risk should now also form part of investment due diligence, not just operational compliance. Funds should consider, for instance, whether targets have clear inventories of their general-purpose AI models and AI systems to more easily assess whether their use of AI is compliant with the Act. Real obligations, real fines Funds using high-risk AI face genuine compliance requirements, human oversight, technical and organisational controls, log retention, incident reporting to EU authorities, and AI literacy obligations across the firm. These are not light-touch disclosure obligations; they require governance infrastructure that many medium-sized fund managers are unlikely to currently have in place. Non-compliance with high-risk AI requirements carries fines of up to 3% of annual worldwide turnover, rising to 7% for outright prohibited AI practices. With enforcement falling to EU Member State regulators, regulatory bodies that are well-resourced and already have a strong enforcement track record are likely to be poised to strike first – the financial sector could well be an early target. When does this bite? The Act came into force back in 2024, but the requirements most relevant to funds (those governing high-risk and limited-risk AI) are not due to apply until 2 August 2026, and even that deadline looks likely to slip further under the European Commission's Omnibus Simplification Package.1 In practice, mid-tier managers may have one to two years yet. That is not a reason to wait. Building governance infrastructure now (e.g. by inventorying AI use cases, mapping regulatory roles and reviewing vendor contracts) will put funds and portfolio companies ahead of enforcement and signal to regulators that AI risk is being managed seriously. A European Act with a hefty impact in Asia The EU AI Act is not just a European problem. Any Asia based fund manager using AI that touches EU staff, EU portfolio companies, or EU investors, is likely subject to the regulations. |
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]
